Yongying Shi

596 total citations
16 papers, 493 citations indexed

About

Yongying Shi is a scholar working on Molecular Biology, Epidemiology and Pharmacology. According to data from OpenAlex, Yongying Shi has authored 16 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Epidemiology and 5 papers in Pharmacology. Recurrent topics in Yongying Shi's work include Natural product bioactivities and synthesis (7 papers), Pharmacological Effects of Natural Compounds (5 papers) and Viral Infections and Immunology Research (4 papers). Yongying Shi is often cited by papers focused on Natural product bioactivities and synthesis (7 papers), Pharmacological Effects of Natural Compounds (5 papers) and Viral Infections and Immunology Research (4 papers). Yongying Shi collaborates with scholars based in China, France and Taiwan. Yongying Shi's co-authors include Demin Zhou, Sulong Xiao, Lihe Zhang, Longlong Si, Han Wang, Fei Yu, Yongmin Zhang, Ge Fu, Xuerui Tan and Chang Chen and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Yongying Shi

16 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yongying Shi China	11	278	153	126	94	70	16	493
Joo‐Youn Lee South Korea	15	282 1.0×	117 0.8×	76 0.6×	39 0.4×	102 1.5×	66	638
Xinli Shi China	19	398 1.4×	155 1.0×	165 1.3×	38 0.4×	44 0.6×	50	767
Kensuke Matsumoto Japan	16	310 1.1×	89 0.6×	153 1.2×	19 0.2×	52 0.7×	41	722
Kiran Dole United States	13	247 0.9×	106 0.7×	130 1.0×	34 0.4×	79 1.1×	22	532
Shengyuan Zhang China	12	195 0.7×	94 0.6×	183 1.5×	70 0.7×	21 0.3×	41	571
E. Musch Germany	14	127 0.5×	130 0.8×	113 0.9×	84 0.9×	25 0.4×	44	623
Ming Mao China	11	392 1.4×	256 1.7×	105 0.8×	61 0.6×	36 0.5×	13	673
Lidya Zolotarov Israel	13	146 0.5×	115 0.8×	199 1.6×	41 0.4×	14 0.2×	18	442
Wenjing Zai China	16	350 1.3×	251 1.6×	116 0.9×	58 0.6×	8 0.1×	26	712
Hongshan Wei China	15	160 0.6×	289 1.9×	112 0.9×	72 0.8×	11 0.2×	67	658

Countries citing papers authored by Yongying Shi

Since Specialization

Citations

This map shows the geographic impact of Yongying Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongying Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongying Shi more than expected).

Fields of papers citing papers by Yongying Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongying Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongying Shi. The network helps show where Yongying Shi may publish in the future.

Co-authorship network of co-authors of Yongying Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Yongying Shi. A scholar is included among the top collaborators of Yongying Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongying Shi. Yongying Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Qiu, Ye, Yongying Shi, Jing Guan, et al.. (2023). Subacute infective endocarditis due to Lodderomyces elongisporus: a case report and review of the literature. Frontiers in Public Health. 11. 1181377–1181377. 1 indexed citations

Liu, Aijun, et al.. (2022). Targeted treprostinil delivery inhibits pulmonary arterial remodeling. European Journal of Pharmacology. 923. 174700–174700. 7 indexed citations

Hou, Ning, Lirong Li, Yongying Shi, et al.. (2021). Azilsartan ameliorates ventricular hypertrophy in rats suffering from pressure overload-induced cardiac hypertrophy by activating the Keap1–Nrf2 signalling pathway. Journal of Pharmacy and Pharmacology. 73(12). 1715–1725. 10 indexed citations

Huang, Hui-Wen, Chufeng Wang, Po‐Liang Lu, et al.. (2018). Evolutionary histories of coxsackievirus B5 and swine vesicular disease virus reconstructed by phylodynamic and sequence variation analyses. Scientific Reports. 8(1). 8821–8821. 6 indexed citations

Shi, Yongying, Longlong Si, Shouxin Wang, et al.. (2017). Synthesis of novel pentacyclic triterpene–Neu5Ac2en derivatives and investigation of their in vitro anti-influenza entry activity. MedChemComm. 8(7). 1531–1541. 12 indexed citations

Si, Longlong, Yongying Shi, Shouxin Wang, et al.. (2017). Synthesis and In Vitro Anti-Influenza Virus Evaluation of Novel Sialic Acid (C-5 and C-9)-Pentacyclic Triterpene Derivatives. Molecules. 22(7). 1018–1018. 10 indexed citations

Wang, Han, Yongying Shi, Longlong Si, et al.. (2016). Design, synthesis and biological evaluation of novel l-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors. European Journal of Medicinal Chemistry. 110. 376–388. 49 indexed citations

Lu, Po‐Liang, Yongying Shi, Chufeng Wang, et al.. (2016). Phylodynamic Characterization of an Ocular-Tropism Coxsackievirus A24 Variant. PLoS ONE. 11(8). e0160672–e0160672. 10 indexed citations

Xu, Han, Yongying Shi, Longlong Si, et al.. (2016). Design, synthesis and biological activity evaluation of novel conjugated sialic acid and pentacyclic triterpene derivatives as anti-influenza entry inhibitors. MedChemComm. 7(10). 1932–1945. 19 indexed citations

10.

Chu, Pei‐Yu, Yu‐Chang Tyan, Yao-Shen Chen, et al.. (2015). Transmission and Demographic Dynamics of Coxsackievirus B1. PLoS ONE. 10(6). e0129272–e0129272. 14 indexed citations

11.

Huang, Hui-Wen, Yao-Shen Chen, Jeff Yi‐Fu Chen, et al.. (2015). Phylodynamic reconstruction of the spatiotemporal transmission and demographic history of coxsackievirus B2. BMC Bioinformatics. 16(1). 302–302. 6 indexed citations

12.

Yu, Fei, Qi Wang, Yongying Shi, et al.. (2014). Development of bivalent oleanane-type triterpenes as potent HCV entry inhibitors. European Journal of Medicinal Chemistry. 77. 258–268. 25 indexed citations

13.

Xiao, Sulong, Qi Wang, Longlong Si, et al.. (2014). Synthesis and Anti‐HCV Entry Activity Studies of β‐Cyclodextrin–Pentacyclic Triterpene Conjugates. ChemMedChem. 9(5). 1060–1070. 47 indexed citations

14.

Si, Longlong, Yufei Wang, Yiming Wu, et al.. (2014). Discovery of Pentacyclic Triterpenoids as Potential Entry Inhibitors of Influenza Viruses. Journal of Medicinal Chemistry. 57(23). 10058–10071. 131 indexed citations

15.

Chen, Yequn, Chang Chen, Xiayi Ke, et al.. (2014). Analysis of Circulating Cholesterol Levels as a Mediator of an Association Between ABO Blood Group and Coronary Heart Disease. Circulation Cardiovascular Genetics. 7(1). 43–48. 60 indexed citations

16.

Yu, Fei, Qi Wang, Zhen Zhang, et al.. (2013). Development of Oleanane-Type Triterpenes as a New Class of HCV Entry Inhibitors. Journal of Medicinal Chemistry. 56(11). 4300–4319. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact